전일 마감가:
$708.41
열려 있는:
$709.11
하루 거래량:
993.07K
Relative Volume:
1.06
시가총액:
$85.53B
수익:
$344.58B
순이익/손실:
$2.83B
주가수익비율:
32.37
EPS:
21.84
순현금흐름:
$1.63B
1주 성능:
+1.04%
1개월 성능:
+3.50%
6개월 성능:
+34.59%
1년 성능:
+33.68%
맥케슨 Stock (MCK) Company Profile
명칭
Mckesson Corporation
전화
972-446-4800
주소
6555 STATE HIGHWAY 161, IRVING, TX
MCK을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MCK
Mckesson Corporation
|
707.00 | 85.53B | 344.58B | 2.83B | 1.63B | 21.84 |
![]()
COR
Cencora Inc
|
291.97 | 55.74B | 303.19B | 1.40B | -638.10M | 7.03 |
![]()
CAH
Cardinal Health Inc
|
151.99 | 32.30B | 222.16B | 1.31B | -486.00M | 5.36 |
![]()
HSIC
Henry Schein Inc
|
66.58 | 8.03B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
AHG
Akso Health Group Adr
|
1.425 | 546.39M | 2.22M | -5.63M | -1.68M | -0.24 |
맥케슨 Stock (MCK) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-04 | 재개 | Mizuho | Neutral |
2024-11-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2024-09-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2024-09-05 | 재확인 | Leerink Partners | Outperform |
2024-08-08 | 재확인 | Mizuho | Neutral |
2024-02-26 | 개시 | Leerink Partners | Outperform |
2024-01-03 | 개시 | Barclays | Overweight |
2023-12-14 | 개시 | Wells Fargo | Equal Weight |
2023-03-31 | 개시 | Citigroup | Buy |
2022-08-22 | 재개 | Morgan Stanley | Overweight |
2022-07-06 | 다운그레이드 | Argus | Buy → Hold |
2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
2022-04-01 | 재개 | Credit Suisse | Outperform |
2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2021-11-02 | 재확인 | Barclays | Overweight |
2021-11-02 | 재확인 | BofA Securities | Buy |
2021-11-02 | 재확인 | Evercore ISI | Outperform |
2021-11-02 | 재확인 | Jefferies | Buy |
2021-03-30 | 업그레이드 | Argus | Hold → Buy |
2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
2020-08-04 | 업그레이드 | Deutsche Bank | Hold → Buy |
2020-05-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
2020-04-23 | 재개 | Credit Suisse | Neutral |
2020-03-18 | 업그레이드 | Goldman | Neutral → Buy |
2020-03-13 | 업그레이드 | Guggenheim | Neutral → Buy |
2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2020-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2019-09-12 | 개시 | Deutsche Bank | Hold |
2019-08-05 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2019-07-22 | 개시 | Guggenheim | Neutral |
2019-01-17 | 개시 | UBS | Neutral |
2018-10-26 | 재확인 | Barclays | Equal Weight |
2018-07-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2018-05-29 | 재확인 | Leerink Partners | Mkt Perform |
2018-03-08 | 개시 | Barclays | Equal Weight |
2018-02-27 | 재개 | BofA/Merrill | Buy |
2018-02-02 | 재확인 | Mizuho | Neutral |
2018-01-24 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
맥케슨 주식(MCK)의 최신 뉴스
McKesson Reports After Close On 5/8 And Options Expire The Next Day - Forbes
McKesson Corporation (NYSE:MCK) is favoured by institutional owners who hold 88% of the company - Yahoo Finance
McKesson (MCK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
McKesson Careers | The future of health starts with you. - McKesson Careers
McKesson (NYSE:MCK) Declares US$0.71 Dividend Per Share Payable July 2025 - simplywall.st
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
McKesson Corporation Declares Quarterly Dividend - Yahoo Finance
McKesson (MCK) Laps the Stock Market: Here's Why - Yahoo
UBS Adjusts Price Target on McKesson to $805 From $708, Maintains Buy Rating - marketscreener.com
McKesson (MCK) Rises Higher Than Market: Key Facts - Yahoo Finance
Here's What to Expect From McKesson's Next Earnings Report - MSN
McKesson Looks to Improve Precision Oncology Access in Community Practice With New Consortium - Precision Medicine Online
McKesson Corporation (MCK): Among the Growing Dividend Stocks with Low PE Ratios - Insider Monkey
Lobbying Update: $1,220,000 of MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS lobbying was just disclosed - Nasdaq
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Here's What To Expect From McKesson's Next Earnings Report - Barchart.com
McKesson Shares Rise Nearly 1% After Key SignalMcKesson (NYSE:MCK) - Benzinga
Jim Cramer Reaffirms McKesson (MCK): “One of the Strongest Stocks in the Market” - MSN
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know - MSN
McKesson Launches Initiative to Advance Precision Medicine in Community Oncology - Dallas Innovates
McKesson will pay $448,000 for hiring bias against Black, Hispanic and white applicants - MSN
McKesson Announces Launch of Specialty and Infusion for Health Systems - McKesson
McKesson Corporation (MCK): One of the Dividend Stocks with Sustainable Payout Ratios - MSN
Jim Cramer Labels McKesson Corporation (MCK) a “Money Machine – A Must-Own Middleman” - Insider Monkey
McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care - HIT Consultant
McKesson is medicine for Elite Investors in market chaos - Citywire
Jim Cramer’s List of 16 Stocks to Buy Right Now - Insider Monkey
Citigroup Adjusts Price Target on McKesson to $800 From $685, Maintains Buy Rating - marketscreener.com
McKesson (MCK) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
McKesson Launches Collaboration to Boost Precision Oncology Adoption - Inside Precision Medicine
McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment - Yahoo Finance
Jim Cramer: McKesson (MCK) Is a “Money Machine” – Funds Keep Flowing In - Insider Monkey
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire
McKesson Corporation (MCK): Among the Best Value Dividend Stocks to Buy According to Billionaires - Yahoo
3 Dividend Stocks Built for Stability as Growth Trades Cool Off - Investing.com
Middlemen Always Work.” – Jim Cramer’s Love for McKesson Corporation (MCK) - Insider Monkey
GS1 US to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
맥케슨 (MCK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):